Tracey Sacco
Fortuna: 4 M $ al 30/06/2026
Fortuna: 4 M $ al 30/06/2026
Tracey Sacco worked at Acceleron Pharma, Inc. from 2012 to 2021 as SVP-Global Marketing & Alliance Management.
Ms. Sacco worked at Scholar Rock Holding Corp.
from 2023 to 2025 as Chief Commercial Officer.
Ms. Sacco completed undergraduate studies at Boston College and earned an MBA from The Leonard N Stern School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/04/2025 | 71.750 ( 0,06 % ) | 4 M $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 01/06/2025 |
| ACCELERON PHARMA INC. | Ventas & Marketing | 01/09/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leonard N Stern School of Business
The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.